| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ADCT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 22.93M | $75.19M | - | |
| CEO | 2.12M | - | - | |
| CFO | 938.1K | - | - | |
| Other | 896.3K | - | - | |
| Other | 841.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Redmile Group, LLC | 10% Owner | Sell | 5,880,415 | $3.34 | $19,636,340.25 | -20.4% | -69.8% | - | |
| Dec 11, 2024 | Redmile Group, LLC | 10% Owner | Buy | 200,000 | $3.05 | $609,000.00 | +1.5% | -22.5% | +88.3% | |
| Dec 4, 2024 | Redmile Group, LLC | 10% Owner | Sell | 25,352 | $2.07 | $52,478.64 | -0.2% | -13.5% | +71.0% | |
| Jul 1, 2024 | Redmile Group, LLC | 10% Owner | Buy | 800,000 | $2.81 | $2,248,000.00 | +6.6% | -14.4% | -27.4% | |
| Jun 17, 2024 | Hug Peter | Director | Sell | 1,193 | $2.89 | $3,447.77 | -0.6% | +9.2% | +15.6% | |
| Jun 17, 2024 | Bizzari Jean-Pierre | Director | Sell | 6,995 | $2.89 | $20,215.55 | -8.1% | +9.2% | +15.6% | |
| Jun 17, 2024 | Monges Viviane | Director | Sell | 1,437 | $2.89 | $4,152.93 | -1.3% | +9.2% | +15.6% | |
| Jun 17, 2024 | Azelby Robert | Director | Sell | 6,995 | $2.89 | $20,215.55 | -11.7% | +9.2% | +15.6% | |
| Jun 17, 2024 | Pfisterer Thomas | Director | Sell | 1,437 | $2.89 | $4,152.93 | -0.7% | +9.2% | +15.6% | |
| Jun 17, 2024 | Sandor Victor | Director | Sell | 6,995 | $2.89 | $20,215.55 | -8.0% | +9.2% | +15.6% |